glp-1 obesity drug news october 21 2025 Alarming rise in weight loss overdoses GLP-1 Agonists: Using Semaglutide, Tirzepatide,
Description
Your bones are more visible now than they used to be
Thus, shared decision-making between surgical, anesthetic, and medical teams is essential to balance risks and benefits [111]
Why should we reconsider how these drugs are prescribed
Boland BB, Mumphrey MB, Hao Z, Townsend RL, Gill B, Oldham S, et al
GLP-1 RA use was identified as an independent risk factor for food retention (OR 9.19, p = 0.0003)
Patients considering GLP-1 discontinuation should work closely with their healthcare team to develop individualized maintenance plans, establish realistic expectations about weight trajectory, and implement close monitoring for weight regain
